免疫检查点抑制剂生物标志物的再思考
A Rethink for IO Biomarkers.
出版信息
Cancer Discov. 2018 Nov;8(11):1342. doi: 10.1158/2159-8290.CD-ND2018-009. Epub 2018 Oct 5.
Abstract
Predictive biomarkers of immunotherapy are growing increasingly complex-incorporating aspects of tumor-intrinsic, immune microenvironmental, and host-related biology-and several new initiatives aim to establish standards for the field to ensure consistency of commercial assays going forward.
摘要
免疫疗法的预测生物标志物变得越来越复杂——包含肿瘤内在、免疫微环境和宿主相关生物学的各个方面——有几个新的计划旨在为该领域建立标准，以确保未来商业检测的一致性。
Zotero 插件